Cargando…
Antileishmanial activity of a formulation of 2-n-propylquinoline by oral route in mice model
2-n-propylquinoline is presently a drug-candidate for the treatment of visceral leishmaniosis in pre-clinical development. As this compound is in an oily state, it needs to be formulated and the objectives of this study are: to prepare a formulation; to demonstrate that the new salted formulation di...
Autores principales: | Campos Vieira, N., Vacus, J., Fournet, A., Baudouin, R., Bories, C., Séon-Méniel, B., Figadère, B., Loiseau, P.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDP Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677589/ https://www.ncbi.nlm.nih.gov/pubmed/22091464 http://dx.doi.org/10.1051/parasite/2011184333 |
Ejemplares similares
-
The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
por: Loiseau, Philippe M., et al.
Publicado: (2022) -
Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance
por: Loiseau, P.M., et al.
Publicado: (2011) -
Chemicals Possessing a Neurotrophin-Like Activity on Dopaminergic Neurons in Primary Culture
por: Schmidt, Fanny, et al.
Publicado: (2009) -
Antileishmanial activity and cytotoxicity of ZnO-based nano-formulations
por: Nazir, Samina, et al.
Publicado: (2019) -
Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
por: Ramos, Guilherme S., et al.
Publicado: (2022)